Concepedia

Martin York

MY

Statistics

Publications

4

Citations

186

H-Index

4

Active since

1993

Affiliations

Emory University(Current)

Research Triangle Park Foundation

Martin York is an author at Emory University specializing in medicine, chemotherapy, and pharmacology.

Publications per year

1993–1997

4

Publications

4

Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.

F. Anthony Greco, Robert A. Figlin, Martin York et al. · Journal of Clinical Oncology · 1996 · 78 citations

Medicine, Oncology, Pharmacology +14

Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma: phase I-II study.

Jerome C. Landry, Michael Koretz, W. C. Wood et al. · Radiology · 1993 · 47 citations

Medicine, Oncology, Surgery +14

Efficacy of Oral Ondansetron, A Selective Antagonist of 5-HT3 Receptors, in the Treatment of Nausea and Vomiting Associated with Cyclophosphamide-Based Chemotherapies

Luigi X. Cubeddu, Kelly Pendergrass, Thomas Ryan et al. · American Journal of Clinical Oncology · 1994 · 42 citations

Medicine, Pharmacology, Pharmacotherapy +16

Oral Ondansetron 8 mg Twice Daily is as Effective as 8 mg Three Times Daily in the Prevention of Nausea and Vomiting Associated with Moderately Emetogenic Cancer Chemotherapy

Thomas Beck, Martin York, A. Y. Chang et al. · Cancer Investigation · 1997 · 19 citations

Medicine, Pharmacology, Pharmacotherapy +17

1–4 of 4